These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39008470)
61. Expression patterns of S100 proteins in melanocytes and melanocytic lesions. Petersson S; Shubbar E; Enerbäck L; Enerbäck C Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263 [TBL] [Abstract][Full Text] [Related]
62. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. Reed JA; McNutt NS; Albino AP Am J Pathol; 1994 Feb; 144(2):329-36. PubMed ID: 8311116 [TBL] [Abstract][Full Text] [Related]
63. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins. Magro CM; Yang SE; Zippin JH; Zembowicz A Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049 [TBL] [Abstract][Full Text] [Related]
64. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235 [TBL] [Abstract][Full Text] [Related]
65. GILT modulates CD4+ T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1. Rausch MP; Hastings KT J Invest Dermatol; 2012 Jan; 132(1):154-62. PubMed ID: 21833020 [TBL] [Abstract][Full Text] [Related]
66. Expression of Melan-A in cutaneous granular cell tumours: a diagnostic pitfall. Van Winden VI; Wong DD; Wood BA; Filion P; Harvey NT Pathology; 2024 Feb; 56(1):47-51. PubMed ID: 37989630 [TBL] [Abstract][Full Text] [Related]
67. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946 [TBL] [Abstract][Full Text] [Related]
68. Clinicopathological and prognostic relevance of Rap1-GAP expression in melanocytic tumors. Weiss J; Biwer B; Schliz M; Jung EG Arch Dermatol Res; 1997 Sep; 289(10):573-7. PubMed ID: 9373716 [TBL] [Abstract][Full Text] [Related]
69. Porcine melanotic cutaneous lesions and lymph nodes: immunohistochemical differentiation of melanocytes and melanophages. Grossi AB; Hyttel P; Jensen HE; Leifsson PS Vet Pathol; 2015 Jan; 52(1):83-91. PubMed ID: 24503437 [TBL] [Abstract][Full Text] [Related]
70. Melan-A, a new melanocytic differentiation marker. Busam KJ; Jungbluth AA Adv Anat Pathol; 1999 Jan; 6(1):12-8. PubMed ID: 10197235 [TBL] [Abstract][Full Text] [Related]
71. Increased expression of stem cell markers in malignant melanoma. Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262 [TBL] [Abstract][Full Text] [Related]
72. Performance of preferentially expressed antigen in melanoma (PRAME) immunohistochemistry for metastatic melanoma in cytology specimens. Saad M; Cantley R; Hao W; Wang Z; Thomas D; Pantanowitz L; Jin X Diagn Cytopathol; 2024 Jul; 52(7):362-368. PubMed ID: 38558495 [TBL] [Abstract][Full Text] [Related]
73. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells. Mehregan DR; Hamzavi I Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068 [TBL] [Abstract][Full Text] [Related]
74. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas. Chen PL; Chen WS; Li J; Lind AC; Lu D Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289 [TBL] [Abstract][Full Text] [Related]
76. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. Kobayashi T; Urabe K; Winder A; Jiménez-Cervantes C; Imokawa G; Brewington T; Solano F; García-Borrón JC; Hearing VJ EMBO J; 1994 Dec; 13(24):5818-25. PubMed ID: 7813420 [TBL] [Abstract][Full Text] [Related]
77. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases. Boyd AS; Shakhtour B; Shyr Y J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467 [TBL] [Abstract][Full Text] [Related]
78. Expression Pattern of Aquaporin 1 and Aquaporin 3 in Melanocytic and Nonmelanocytic Skin Tumors. Osorio G; Zulueta-Dorado T; González-Rodríguez P; Bernabéu-Wittel J; Conejo-Mir J; Ramírez-Lorca R; Echevarría M Am J Clin Pathol; 2019 Sep; 152(4):446-457. PubMed ID: 31305898 [TBL] [Abstract][Full Text] [Related]
79. Stathmin is a potential therapeutic target but not a prognostic marker in melanoma: an immunohistochemical study of 323 melanocytic lesions. Dundr P; Simon K; Němejcová K; Bártů M; Tichá I; Michálková R; Jakša R; Věcková Z; Kodet O Melanoma Res; 2019 Apr; 29(2):157-162. PubMed ID: 30422880 [TBL] [Abstract][Full Text] [Related]
80. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Jäger E; Ringhoffer M; Karbach J; Arand M; Oesch F; Knuth A Int J Cancer; 1996 May; 66(4):470-6. PubMed ID: 8635862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]